The pipeline for drugs for control and elimination of neglected tropical diseases: 2. Oral anti-infective drugs and drug combinations for off-label usearticle Published on 2023-10-312024-09-05 Journal: Parasites & Vectors [Category] update2024, [키워드] Acedapsone albendazole amoxicillin Artemether artemisinins Arterolane artesunate Azithromycin azoles Balapiravir celgosivir Chloroquine clarithromycin Clavulanate CURE ID dapsone Diethylcarbamazine disulfiram doxycycline Drug reprofiling Drug repurposing fluconazole Imatinib Isavuconazonium itraconazole Ivermectin ketoconazole Levamisole Lumefantrine Mebendazole mefloquine Moxidectin moxifloxacin Neglected topical diseases nitazoxanide off-label use Oxamniquine Oxantel Piperaquine Posaconazole Praziquantel Pyrantel pamoate ravuconazole ribavirin rifampicin Rifapentine Sparfloxacin streptomycin Tribendimidine UV-4B [DOI] 10.1186/s13071-023-05909-8 PMC 바로가기 [Article Type] article
Pharmacokinetic and pharmacodynamic considerations for treating sarcoptic mange with cross-relevance to Australian wildlifeRegular article Published on 2023-03-052024-09-05 Journal: International Journal for Parasitology: Drugs and Drug Resistance [Category] update2024, [키워드] drug resistance Fluralaner Ivermectin Ligand-gated ion channels Moxidectin Sarcoptes scabiei Sarcoptic mange scabies Treatment [DOI] 10.1016/j.ijpddr.2023.02.004 PMC 바로가기 [Article Type] Regular article
Moxidectin and Ivermectin Inhibit SARS-CoV-2 Replication in Vero E6 Cells but Not in Human Primary Bronchial Epithelial Cells목시덱틴과 이버멕틴은 Vero E6 세포에서 SARS-CoV-2 복제를 억제하지만 인간의 1차 기관지 상피 세포에서는 억제하지 않습니다Article Published on 2022-01-182022-09-11 Journal: Antimicrobial Agents and Chemotherapy [Category] SARS, 치료제, [키워드] ALI alleviate anti-parasitic Anti-SARS-CoV-2 Activity Antiviral antiviral activity Antiviral effect antiviral therapies bronchial caution Cell cell entry Concentration COVID-19 disease COVID-19 patient COVID-19 patients drug epithelial cells Evidence exhibited experiment following head Head-to-head comparison Health Organization High-dose Human humans in vitro in vitro model in vitro result in vivo Infection inhibit SARS-CoV-2 Interpretation Ivermectin limit Moxidectin moxidectin. performed regimen respiratory epithelial cells SARS-CoV-2 SARS-COV-2 infection severe COVID-19 disease shown switching therapy these compound these compounds treat Treatment triggered unlikely Vero Cell Vero cells Vero E6 VERO E6 cells virus World Health Organization [DOI] 10.1128/AAC.01543-21 PMC 바로가기 [Article Type] Article